For years, the cattle industry has relied on florfenicol (antibiotic) to treat bacterial causes of bovine respiratory disease (BRD). At the same time, the industry has relied on flunixin meglumine (NSAID) to treat the fever associated with BRD.
RESFLOR GOLD changes all that. It is a unique formulation of florfenicol and flunixin meglumine. We say RESFLOR GOLD is a “unique” formulation because florfenicol and flunixin meglumine cannot simply be mixed together to create RESFLOR GOLD. When they are mixed that way, a gelatinous substance results; it could not be administered by any route.
The technology that formulated RESFLOR GOLD brought with it two bonus features of the product:
What this new technology means to the cattle industry is that BRD therapy can now be provided simply, conveniently and cost-effectively.
IMPORTANT SAFETY INFORMATION: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. This product contains material that can be irritating to skin and eyes. Animals intended for human consumption must not be slaughtered within 38 days treatment. This product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. Do not use in animals that have shown hypersensitivity to florfenicol or flunixin. Not for use in animals intended for breeding purposes. The effects of florfenicol and flunixin on bovine reproductive performance, pregnancy, and lactation have not been determined. When administered according to the label directions, RESFLOR GOLD may induce a transient local reaction in the subcutaneous and underlying muscle tissue. Click here for full product information.